Expert recommendations adjust drug dosing in liver cirrhosis, highlighting the need for unified guidelines.
Expert recommendations for dosing in cirrhosis showed marked variability and limited concordance with prescribing information, underscoring the need for harmonised interdisciplinary guidance integrating pharmacokinetic evidence and clinical feasibility.
No takes yet. Share an insight, caveat, or question.
Dafonte et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: